These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26588584)

  • 1. Caffeine Impact on Metabolic Syndrome Components Is Modulated by a CYP1A2 Variant.
    Platt DE; Ghassibe-Sabbagh M; Salameh P; Salloum AK; Haber M; Mouzaya F; Gauguier D; Al-Sarraj Y; El-Shanti H; Zalloua PA; Abchee AB
    Ann Nutr Metab; 2016; 68(1):1-11. PubMed ID: 26588584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study.
    Nordestgaard AT; Thomsen M; Nordestgaard BG
    Int J Epidemiol; 2015 Apr; 44(2):551-65. PubMed ID: 26002927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of caffeine intake and CYP1A2 genotype with ovarian cancer.
    Goodman MT; Tung KH; McDuffie K; Wilkens LR; Donlon TA
    Nutr Cancer; 2003; 46(1):23-9. PubMed ID: 12925300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
    Kotsopoulos J; Ghadirian P; El-Sohemy A; Lynch HT; Snyder C; Daly M; Domchek S; Randall S; Karlan B; Zhang P; Zhang S; Sun P; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):912-6. PubMed ID: 17507615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
    Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
    Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee consumption and risk of type 2 diabetes.
    Palatini P
    Diabetologia; 2015 Jan; 58(1):199-200. PubMed ID: 25344635
    [No Abstract]   [Full Text] [Related]  

  • 7. Coffee, CYP1A2 genotype, and risk of myocardial infarction.
    Cornelis MC; El-Sohemy A; Kabagambe EK; Campos H
    JAMA; 2006 Mar; 295(10):1135-41. PubMed ID: 16522833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
    Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
    Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies.
    Jiang X; Zhang D; Jiang W
    Eur J Nutr; 2014 Feb; 53(1):25-38. PubMed ID: 24150256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
    Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.
    Popat RA; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; McGuire V; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
    Eur J Neurol; 2011 May; 18(5):756-65. PubMed ID: 21281405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients.
    Palatini P; Benetti E; Mos L; Garavelli G; Mazzer A; Cozzio S; Fania C; Casiglia E
    Eur J Epidemiol; 2015 Mar; 30(3):209-17. PubMed ID: 25595320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.
    Chuang YH; Lill CM; Lee PC; Hansen J; Lassen CF; Bertram L; Greene N; Sinsheimer JS; Ritz B
    Neuroepidemiology; 2016; 47(3-4):192-200. PubMed ID: 28135712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction.
    Mahdavi S; Palatini P; El-Sohemy A
    JAMA Netw Open; 2023 Jan; 6(1):e2247868. PubMed ID: 36701157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
    Palatini P; Ceolotto G; Ragazzo F; Dorigatti F; Saladini F; Papparella I; Mos L; Zanata G; Santonastaso M
    J Hypertens; 2009 Aug; 27(8):1594-601. PubMed ID: 19451835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials.
    Cai L; Ma D; Zhang Y; Liu Z; Wang P
    Eur J Clin Nutr; 2012 Aug; 66(8):872-7. PubMed ID: 22713771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking.
    Rodenburg EM; Eijgelsheim M; Geleijnse JM; Amin N; van Duijn CM; Hofman A; Uitterlinden AG; Stricker BH; Visser LE
    Am J Clin Nutr; 2012 Jul; 96(1):182-7. PubMed ID: 22648710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine, diabetes, cognition, and dementia.
    Biessels GJ
    J Alzheimers Dis; 2010; 20 Suppl 1():S143-50. PubMed ID: 20182038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee, tea and diabetes: the role of weight loss and caffeine.
    Greenberg JA; Axen KV; Schnoll R; Boozer CN
    Int J Obes (Lond); 2005 Sep; 29(9):1121-9. PubMed ID: 15925959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.